🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Continuous Vital Sign Monitoring in a Surgical Ward

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Akershus
NCT07690267 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Unsafe patient care remains a major contributor to global morbidity and mortality. In surgical wards, postoperative patients are typically monitored intermittently using the National Early Warning Score (NEWS-2), leaving periods during which clinical deterioration may go undetected. Continuous vital sign monitoring (CVSM) using wearable sensors offers the potential for earlier identification of deterioration compared with intermittent assessments. CVSM was introduced in a hospital ward as part of a hospital-initiated pilot implementation and is used alongside standard monitoring with NEWS-2. The purpose of the study is to evaluate this implementation. This observational study uses a pragmatic, quasi-experimental, multi-method, longitudinal design. The overall aims of the study are to evaluate the impact of CVSM implementation on patient outcomes, to explore healthcare professionals' pe

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients aged 18 years or older admitted to the gastro-surgical ward. * Healthcare professionals aged 18 years or older employed in the participating wards for survey participation. * Nursing staff with at least 6 months of work experience and experience using CVSM for participation in qualitative focus group interviews. Exclusion Criteria: * Patients with delirium. * Patients with cognitive impairment interfering with sensor use. * Patients who decline participation. * Patients with allergy to electrode adhesives.
💊

What it tests

  • Continuous Vital Sign Monitoring (CVSM)
📍

Where

1 site
Akershus University Hospital HF
Lørenskog, Norway
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy